EDAP ADRs Fall After 1Q Loss Widens More Than Expected

Dow Jones
05/16
 

By Sarina Isaacs

 

American depositary receipts of EDAP slipped after the maker of robotic energy-based therapies posted a worse-than-expected loss for the first quarter.

EDAP's ADRs were recently down 21%, to $1.71, and have lost about three-quarters of their value over the past year.

The Vaulx-en-Velin, France, company on Thursday reported a first-quarter loss of $7.5 million, or 20 cents a share, compared with a loss of $4.9 million, or 13 cents a share, a year earlier.

Analysts were looking for a loss of 18 cents a share, according to FactSet.

Revenue fell to $14.3 million from $16.1 million in the prior year and below analysts' expectation of $16 million.

EDAP also reiterated its prior full-year guidance, expecting revenue growth of 16% to 25% in its core High Intensity Focused Ultrasound business and a decline of 20% to 25% for revenue in its non-core businesses.

 

Write to Sarina Isaacs at sarina.isaacs@wsj.com

 

(END) Dow Jones Newswires

May 15, 2025 13:57 ET (17:57 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10